Pharmacogenetics as predictor of sunitinib and mTOR inhibitors toxicity in patients with metastatic renal cell carcinoma (mRCC).
Yuksel Urun
No relevant relationships to disclose
Kathryn P. Gray
No relevant relationships to disclose
Sabina Signoretti
No relevant relationships to disclose
David F. McDermott
No relevant relationships to disclose
Michael B. Atkins
No relevant relationships to disclose
Megan E. Lampron
No relevant relationships to disclose
Matthew Freedman
No relevant relationships to disclose
Toni K. Choueiri
No relevant relationships to disclose
Mark M Pomerantz
No relevant relationships to disclose